Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study
- PMID: 16798756
- PMCID: PMC1526943
- DOI: 10.1136/bmj.38834.421713.2F
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study
Erratum in
- BMJ. 2006 Sep 2;333(7566):468
Abstract
Objective: To determine the incidence of methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA and MSSA) bacteraemia in inpatients and associated mortality within 30 days after diagnosis.
Design: Anonymised record linkage study of data from hospital information systems and microbiology databases.
Setting: Teaching hospital and district general hospital in Oxfordshire.
Participants: Inpatients aged 18 or over admitted to a teaching hospital between 1 April 1997 and 31 March 2004 and to a district general hospital between 1 April 1999 and 31 March 2004. The main part of the study comprised 216 644 inpatients; patients admitted to haematology, nephrology, or oncology services were not included because most were managed as outpatients.
Outcome measures: Nosocomial MSSA and MRSA bacteraemia; death in hospital within 30 days after bacteraemia.
Results: Rates of S aureus bacteraemia rose between 1997 and 2003, and MRSA was responsible for this increase. Overall mortality 30 days after bacteraemia was 29%. The crude odds ratio for death after MRSA bacteraemia compared with MSSA bacteraemia was 1.49 (95% confidence interval 0.99 to 2.26).
Conclusion: The spread of MRSA has greatly increased the overall number of cases of S aureus bacteraemia and has contributed to short term mortality after S aureus bacteraemia.
Figures







Comment in
-
Surveillance and management of all types of Staphylococcus aureus bacteraemia.BMJ. 2006 Aug 5;333(7562):269-70. doi: 10.1136/bmj.333.7562.269. BMJ. 2006. PMID: 16888291 Free PMC article. No abstract available.
Similar articles
-
MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.BMJ. 2005 Oct 29;331(7523):992. doi: 10.1136/bmj.38558.453310.8F. Epub 2005 Sep 9. BMJ. 2005. PMID: 16155048 Free PMC article.
-
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.Clin Microbiol Infect. 2010 Jun;16(6):722-8. doi: 10.1111/j.1469-0691.2009.02902.x. Epub 2009 Aug 27. Clin Microbiol Infect. 2010. PMID: 19712112
-
Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.Int J Antimicrob Agents. 2011 Oct;38(4):331-5. doi: 10.1016/j.ijantimicag.2011.05.013. Epub 2011 Jul 28. Int J Antimicrob Agents. 2011. PMID: 21798720 Clinical Trial.
-
Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.J Antimicrob Chemother. 2009 Sep;64 Suppl 1:i11-7. doi: 10.1093/jac/dkp260. J Antimicrob Chemother. 2009. PMID: 19675013 Review.
-
MRSA bacteraemia.Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S66-70. doi: 10.1016/j.ijantimicag.2007.06.023. Epub 2007 Sep 17. Int J Antimicrob Agents. 2007. PMID: 17875386 Review.
Cited by
-
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.PLoS One. 2010 Jul 16;5(7):e11562. doi: 10.1371/journal.pone.0011562. PLoS One. 2010. PMID: 20661278 Free PMC article.
-
Vegetation Formation in Staphylococcus Aureus Endocarditis Inversely Correlates With RNAIII and sarA Expression in Invasive Clonal Complex 5 Isolates.Front Cell Infect Microbiol. 2022 Jul 4;12:925914. doi: 10.3389/fcimb.2022.925914. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860377 Free PMC article.
-
The importance of diagnosing neck pain.Clin Rheumatol. 2008 Aug;27(8):1061-2. doi: 10.1007/s10067-008-0863-7. Epub 2008 Mar 21. Clin Rheumatol. 2008. PMID: 18357501
-
Risk factors for methicillin resistant Staphylococcus aureus: a multi-laboratory study.PLoS One. 2014 Feb 26;9(2):e89579. doi: 10.1371/journal.pone.0089579. eCollection 2014. PLoS One. 2014. PMID: 24586887 Free PMC article.
-
Assessing the Potential Impact of a Long-Acting SkinDisinfectant in the Prevention of Methicillin-Resistant Staphylococcus aureus Transmission.Int J Environ Res Public Health. 2020 Feb 26;17(5):1500. doi: 10.3390/ijerph17051500. Int J Environ Res Public Health. 2020. PMID: 32110949 Free PMC article.
References
-
- British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39: 253-90. - PubMed
-
- Department of Health. MRSA surveillance system: results. www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsStatist... (accessed 20 May 2006).
-
- Reid J. Bloodborne MRSA infection rates to be halved by 2008. www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotic... (accessed 27 Apr 2006).
-
- Griffiths C, Lamagni TL, Crowcroft NS, Duckworth G, Rooney C. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat Q 2004(21): 15-22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous